STOCK TITAN

Veracyte to Release Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Veracyte, Inc. (Nasdaq: VCYT) will release financial results for Q4 and full-year 2023 on February 22, 2024. A conference call and webcast will follow to discuss the results and provide a business update. The webcast replay will be available on the company's website.
Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the fourth quarter and full-year 2023 after the close of market on Thursday, February 22, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.

The conference call will be webcast live from the company’s website and will be available via the following link: https://edge.media-server.com/mmc/p/tkiac6t9. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company’s website at https://investor.veracyte.com/events-presentations.

The conference call dial-ins can be accessed by registering at: https://register.vevent.com/register/BI38de228ea0a04e0ab786cfe56be5ca1b

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).

Investors

Shayla Gorman

investors@veracyte.com

(619) 393-1545

Media

Tracy Morris

media@veracyte.com

(650) 380-4413

Source: Veracyte, Inc.

FAQ

When will Veracyte release its financial results for Q4 and full-year 2023?

Veracyte will release its financial results on February 22, 2024.

What is the ticker symbol for Veracyte, Inc.?

The ticker symbol for Veracyte is VCYT.

Where can I access the webcast replay of the conference call?

The webcast replay will be accessible on the company's website at https://investor.veracyte.com/events-presentations.

What time will the conference call and webcast discussing financial results take place?

The conference call and webcast will take place at 4:30 p.m. Eastern Time on February 22, 2024.

How can I access the live webcast of the conference call?

The live webcast can be accessed from the company's website via the following link: https://edge.media-server.com/mmc/p/tkiac6t9.

Veracyte, Inc.

NASDAQ:VCYT

VCYT Rankings

VCYT Latest News

VCYT Stock Data

1.74B
76.84M
0.79%
104.45%
4%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SOUTH SAN FRANCISCO